GlassScriptPhysician profile
Alexa M Dendulk
NPI 1477160836
$1,964.59
in general payments reported to CMS, 2019-2025
17 companies · $686 in 2025
The $686 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $307 · 2023: $214 · 2024: $528 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,408.17 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $475.45 | 2022-2024 | Watchman Flx |
| Cvrx, INC. | $284.92 | 2022-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.48 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $201.08 | 2021-2025 | Lifevest |
| Amgen INC. | $189.34 | 2023-2025 | Repatha, Repatha |
| Abbott Laboratories | $138.86 | 2021-2025 | Freestyle Libre 3 |
| Pfizer INC. | $138.30 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $71.02 | 2024-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $58.01 | 2025 | Optimizer |
| Medtronic, INC. | $45.00 | 2022 | |
| Alnylam Pharmaceuticals INC. | $37.08 | 2025 | Onpattro |
| Lantheus Medical Imaging, INC. | $21.25 | 2023 | Definity |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 | |
| Novo Nordisk INC | $18.77 | 2024 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $16.54 | 2025 | Camzyos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $15.69 | 2024 | Nexletol |
| Sanofi-Aventis U.S. LLC | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Dendulk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.